ENXTPA:VIRPPharmaceuticals
Assessing Virbac (ENXTPA:VIRP) Valuation As Mixed Short‑Term Moves Contrast With Strong Recent Momentum
Virbac (ENXTPA:VIRP) has been drawing attention after recent share price moves, with the stock showing mixed short term returns and stronger performance over the past 3 months and year for long term holders.
See our latest analysis for Virbac.
Recent trading has been choppy, with a 1 day share price return of a 1.51% decline and a flat 7 day move. However, the 90 day share price return of 16.59% and 1 year total shareholder return of 14.69% suggest that momentum has been building rather than...